Adverum Biotechnologies Inc. logo

Adverum Biotechnologies Inc.

ADVM | NASDAQ
Chart Builder DCF Calculator
$4.36
$0 (0.00%)
At close: Dec 9, 2025, 4:00 PM ET

Market Data

Market Cap
$96.26M
Enterprise Value
$159.14M
Beta
0.87
Average Volume
702.08K
Shares Outstanding (Diluted)
23.49M
Shares Change YoY
12.51%
Institutional Ownership
61.15%
Exchange
NASDAQ
ISIN
US00773U2078

Price Performance

Price Change 1M
4.8%
Price Change 3M
7.4%
Price Change 6M
69.0%
Price Change YTD
-9.2%
Price Change 1Y
-8.0%
Price Change 3Y
N/A
Price Change 5Y
-96.5%
1M CAGR (ann.)
2.8%
1Y CAGR (ann.)
-23.4%
5Y CAGR (ann.)
-50.0%
All-Time CAGR
-30.7%

Valuation

PE Ratio
-0.51
Forward PE
N/A
PEG Ratio
0.01
Forward PEG
0.10
PS Ratio
N/A
Forward PS
1.80
PB Ratio
-1.73
P/FCF Ratio
-0.70
P/Adj. FCF Ratio
-0.66
P/OCF Ratio
-0.93
EV/Sales
N/A
EV/EBIT
-0.78
EV/EBITDA
-0.79
EV/FCF
-1.15
Earnings Yield
-196.8%
FCF Yield
-143.8%
Adj. FCF Yield
-151.7%

Financial Health

Net Cash
$20.25M
Total Debt
$88.94M
Cash & Short-Term Investments
$26.06M
Total Assets
$72.4M
Current Ratio
0.65
Quick Ratio
0.65
Debt / Equity Ratio
-1.60
Debt / EBITDA
-0.44
Debt / FCF
-0.64
OCF / Debt
-1.55
Interest Coverage
0.00
Altman Z-Score
-32.54
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-5.5%

Returns

Return on Assets
-198.7%
Return on Equity
872.8%
Return on Invested Capital
-433.6%
Return on Capital Employed
-524.7%
Return on Tangible Assets
-198.7%

Historical Growth (CAGR)

Revenue CAGR 3Y
-117.4%
Revenue CAGR 5Y
-57.9%
Revenue CAGR 10Y
-3.0%
EPS CAGR 3Y
-64.8%
EPS CAGR 5Y
-46.5%
EPS CAGR 10Y
-17.0%
FCF CAGR 3Y
-23.7%
FCF CAGR 5Y
0.1%
FCF CAGR 10Y
-11.4%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
16
EPS Growth Next 3Y
19.3%
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 11, 2025
EPS Estimate (next Q)
-$1.80
EPS Growth Est (next Q)
38.5%
Revenue Est (next Q)
$200K
Revenue Growth Est (next Q)
-80.0%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$8.90
Price Target Upside
104.1%

Cash Flow

Operating Cash Flow
$-137.9M
Free Cash Flow
$-138.45M
Adj. Free Cash Flow
$-146M
FCF Per Share
-$4.69
OCF Per Share
-$4.67
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$-465K
Operating Income
$-207.32M
EBITDA
$-201.9M
Net Income
$-204.39M
EPS (Diluted)
-$8.58
Revenue / Employee
N/A
Profit / Employee
$-1.32M
Employees
155

© 2026 bestshares.com. All rights reserved.